Compound ID | 1444
Synonym(s): Ceftaroline fosamil
Class: Beta-lactam (cephalosporin)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Anti-MRSA and Enterobacteriaceae; indicated for acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia |
Institute where first reported: | Forest Laboratories, USA/ AbbVie/ Allergan/ Cerexa Inc. |
Year first mentioned: | 2008 |
Highest developmental phase: | Approved by FDA in 2010; Approved for pediatric use in 2016 |
Chemical structure(s): | |
Canonical SMILES: | CCO/N=C(/C1=NSC(=N1)NP(=O)(O)O)\C(=O)N[C@@H]2C(=O)N3C(=C(CS[C@H]23)SC4=NC(=CS4)C5=CC=[N+](C)C=C5)C(=O)[O-] |
Isomeric SMILES: | CCO/N=C(/C1=NSC(=N1)NP(=O)(O)O)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)[O-] |
InChI: | InChI=1S/C22H21N8O8PS4/c1-3-38-26-13(16-25-21(43-28-16)27-39(35,36)37)17(31)24-14-18(32)30-15(20(33)34)12(9-40-19(14)30)42-22-23-11(8-41-22)10-4-6-29(2)7-5-10/h4-8,14,19H,3,9H2,1-2H3,(H4-,24,25,27,28,31,33,34,35,36,37)/b26-13-/t14-,19-/m1/s1 |
InChI Key: | ZCCUWMICIWSJIX-NQJJCJBVSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/9852981 |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/9938701 |
External links: | |
Guide to Pharmacology: | ceftaroline fosamil |
Main Source: | https://aac.asm.org/content/53/6/2360 |
Citations: |
|